Jonathan S. Leff, Director at ZYMOGENETICS INC (ZGEN), bought 146,900 shares at $9.49 ($1.4M) on 2008-02-25, disclosed to the SEC on 2008-02-27.
Open-market purchase of $1.4M ZGEN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.40 | 400 | $4K | 0.3% |
| 2 | $9.46 | 200 | $2K | 0.1% |
| 3 | $9.47 | 200 | $2K | 0.1% |
| 4 | $9.49 | 400 | $4K | 0.3% |
| 5 | $9.50 | 4,200 | $40K | 2.8% |
| 6 | $9.52 | 1,200 |
| $11K |
| 0.8% |
| 7 | $9.53 | 841 | $8K | 0.6% |
| 8 | $9.54 | 2,659 | $25K | 1.8% |
| 9 | $9.55 | 4,345 | $41K | 2.9% |
| 10 | $9.56 | 8,600 | $82K | 5.8% |
| 11 | $9.57 | 21,700 | $208K | 14.7% |
| 12 | $9.58 | 6,000 | $57K | 4.1% |
| 13 | $9.59 | 12,939 | $124K | 8.8% |
| 14 | $9.60 | 21,161 | $203K | 14.4% |
| 15 | $9.61 | 3,000 | $29K | 2.0% |
| 16 | $9.62 | 6,400 | $62K | 4.4% |
| 17 | $9.63 | 9,300 | $90K | 6.3% |
| 18 | $9.64 | 5,700 | $55K | 3.9% |
| 19 | $9.65 | 8,408 | $81K | 5.8% |
| 20 | $9.66 | 3,892 | $38K | 2.7% |
| 21 | $9.67 | 7,200 | $70K | 4.9% |
| 22 | $9.68 | 5,700 | $55K | 3.9% |
| 23 | $9.69 | 5,755 | $56K | 4.0% |
| 24 | $9.70 | 1,900 | $18K | 1.3% |
| 25 | $9.71 | 1,600 | $16K | 1.1% |
| 26 | $9.72 | 800 | $8K | 0.6% |
| 27 | $9.73 | 500 | $5K | 0.3% |
| 28 | $9.45 | 1,100 | $10K | 0.7% |
| 29 | $9.49 | 100 | $949 | 0.1% |
| 30 | $9.50 | 700 | $7K | 0.5% |
| Total | $9.60 avg | 146,900 | $1.4M | 100% |
| Filing → |
| ALTH | BUY | 2008-05-30 | $19.7M | — | Filing → |
| ZGEN | BUY | 2008-03-11 | $489K | — | Filing → |
| ZGEN | BUY | 2008-03-07 | $917K | — | Filing → |